AmgenvsPrestige Consumer Healthcare

AMGN and PBH stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$440.82

Value $238B

+0.36%
AMGN's page

PBH

Prestige Consumer Healthcare Inc.

$50.27

Value $2.4B

+1.35%
PBH's page

Amgen (AMGN) has a market value of $238B and Prestige Consumer Healthcare (PBH) $2.4B. Over the last year, with dividends, AMGN moved +32.3% and PBH -14.1%. The P/E is 25.3 for AMGN and 15.4 for PBH. Dividend yield: AMGN 2.25%, PBH none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$238B

    PBH$2.4B

    AMGN is 100 times PBH

  • Revenue, 12 months

    AMGN$38.9B

    PBH$1.2B

    AMGN is 33 times PBH

  • Net income, 12 months

    AMGN$9.4B

    PBH$155M

    AMGN is 61 times PBH

  • Operating margin

    AMGN32.4%

    PBH25.0%

    7.4 points apart

  • ROIC

    AMGN16.2%

    PBH7.0%

    9.2 points apart

  • P/E

    AMGN25.3

    PBH15.4

    AMGN is 1.6 times PBH

  • Dividend yield

    AMGN2.3%

    PBH0.0%

    2.3 points apart

  • 5-year return

    AMGN+147.8%

    PBH-13.7%

    161.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+147.8%

PBH-13.7%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsPBHWith dividends
1 year since November 19, 2025+32.3%Price +28.7%-14.1%Price -14.1%
3 years since November 20, 2023+80.3%+21.7% a yearPrice +66.1%-14.6%-5.1% a yearPrice -14.6%
5 years since November 19, 2021+147.8%+19.9% a yearPrice +113.9%-13.7%-2.9% a yearPrice -13.7%
10 years since November 21, 2016+305.1%+15.0% a yearPrice +202.9%+2.5%+0.2% a yearPrice +2.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenPBHPrestige Consumer Healthcare

Valuation

AMGNPBH
Valuation
Price$440.82$50.27
Market value$238B$2.4B
Enterprise value (EV)$278B$4.4B
P/E25.315.4
P/E, 5-year median23.016.3
P/B16.61.2
EV/EBIT22.115.2
Free cash flow yield4.0%9.0%

Results and growth

AMGNPBH
Results and growth
Revenue, 12 months$38.9B$1.2B
Net income, 12 months$9.4B$155M
Free cash flow, 12 months$9.6B$214M
Earnings per share, 12 months$17.25$3.24
Revenue growth, year on year10.0%-4.3%
Revenue growth a year, past+7.6%over 5 years+2.9%over 5 years
EPS growth a year, past+2.9%over 5 years+3.8%over 5 years

Margins and returns on capital

AMGNPBH
Margins and returns on capital
Gross margin70.9%52.5%
Operating margin32.4%25.0%
Net margin24.1%13.3%
ROIC16.2%7.0%
ROE87.8%8.3%

Balance sheet

AMGNPBH
Balance sheet
Cash$13.2B$47M
Total debt$54.0B$2.1B
Net debt / EBITDA2.36.4
Interest cover4.8×–

Dividends and buybacks

AMGNPBH
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield–6.6%
Shareholder yield2.3%6.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or PBH

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Prestige Consumer Healthcare?

By market value, Amgen ($238B) is about 99.8 times Prestige Consumer Healthcare ($2.4B), at today's prices.

How did AMGN and PBH stock do over the last 10 years?

Since November 21, 2016, AMGN's price moved +202.9% and PBH's +2.5%. With dividends: AMGN +305.1% (+15.0% a year), PBH +2.5% (+0.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or PBH?

The dividend yield at today's price is 2.25% for Amgen and none for Prestige Consumer Healthcare. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and PBH?

At today's price, the P/E is 25.3 for AMGN and 15.4 for PBH. The median of the last five years was 23.0 and 16.3, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Prestige Consumer Healthcare?

Over the last twelve months, the net margin was 24.1% for Amgen and 13.3% for Prestige Consumer Healthcare, and the operating margin 32.4% and 25.0%. Revenue was $38.9B and $1.2B.

Which is the better investment, Amgen or Prestige Consumer Healthcare?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.